The company has announced a new parent name and a profitable second fiscal quarter, with ongoing progress across the EU.
The new Research and Markets report estimates the market will grow at a CAGR of 19.6 per cent.
2021 has been a good year for the cannabis industry, says the new Brightfield Group report.
Research and Markets has projected the global hemp derivatives market to grow at a CAGR of 19.7 per cent from 2021 to 2028.
The global cannabinoid pharmaceuticals market has been projected to reach £1.53bn (€1.8bn).
Fortune Business Insights says the market will grow at a CAGR of 50.9 per cent from 2020 to 2027.
Synbiotic SE has acquired 50.1 per cent of Daniel Kruse’s cannabis group in what it has described as the most significant merger for the European cannabis sector.Â
Equinox has announced its intention to trade on the AIM market of the London Stock Exchange.
The proceeds will accelerate its plans to build an international medical cannabis company.
London’s annual cannabis event returned to explore all aspects of Europe’s cannabis industry.Â
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
